Ownership
Private
Therapeutic Areas
Psychiatry
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Non-pharmacological therapy

OPTT Health General Information

OPTT Health has demonstrated efficacy in clinical settings, including a reported 40% reduction in depression symptoms with its clinical partners. The company’s solutions have been validated through more than ten completed clinical trials, supporting their effectiveness for depression and anxiety management using online cognitive behavioral therapy modules powered by AI/NLP analytics[1][3].

Contact Information

Primary Industry
Digital Health Medical Devices
Corporate Office
Toronto, Ontario
Canada

Drug Pipeline

No pipeline data available

For full access to OPTT Health's pipeline data

Book a demo

Key Partnerships

Telus Health, Queen's University

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

OPTT Health Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view OPTT Health's complete valuation and funding history, request access »

OPTT Health Financial Metrics